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 The grant concerned chromate [Cr(VI)] bioremediation and it was our aim from the outset to 
construct individual bacterial strains capable of improved bioremediation of multiple pollutants and to 
identify the enzymes suited to this end. Bacteria with superior capacity to remediate multiple pollutants 
can be an asset for the cleanup of DOE sites as they contain mixed waste. I describe below the progress 
made during the period of the current grant, providing appropriate context. 
1. Chromate toxicity. Reduction of chromate is toxic to bacteria, as is illustrated in Fig. 1 [1, 2] 
for P. putida and E. coli: their growth is markedly inhibited and the cells acquire abnormal shapes. The 
external accumulation shown in P. putida cell (top right) have also been reported in Caulobacter 
crescentus grown in the presence of uranyl [3]. 
2. Soluble “chromate reductases”. Some bacteria might be able to respire chromate for energy 
generation.  This has been suggested for Enterobacter cloacae and might be true of others [4]. The 
electron transport chains of iron and sulfate reducing bacteria can also reduce chromate and other metals 
and radionuclides but no energy is evidently derived from many of these processes [5, 6].  
We found that all of some twelve different bacteria we tested reduced chromate using soluble 
enzymes [1]. These included species of Pseudomonas, Shewanella, Deinococcus and Bacillus. P. 
fluorescens, S. oneidensis, D. radiodurans and Vibrio harveyi were among the most active (114 – 193 
nmol chromate converted/mg cell protein/h). Soluble enzymes for chromate reduction have the potential 
advantage in that the locus for reduction is intracellular which may promote immobilization and minimize 
re-oxidation of the reduced species.  
3. Soluble one-electron chromate reducers. Why is Cr(IV) toxic to bacteria?  Several metabolic 
enzymes of the cell, such as lipoyl dehydrogenase, glutathione and cytochrome b5 reductases, with the 
physiological role of energy generation and biosynthesis, can vicariously reduce chromate.  Using 
electron spin resonance (ESR), Shi & Dalal [7] showed that such enzymes reduce chromate by one 
electron reduction, generating Cr(V). This is a highly reactive radical, and rapidly transfers its electron to 
molecular oxygen or, depending on the conditions to another molecule, generating reactive oxygen 
species (ROS) or other equally destructive oxidizing agents. Continual activity of the one electron 
reducers causes Cr(VI) to shuttle back and forth between the VI and V valence states, generating little net 
reduced Cr but large amounts of ROS; this drains the cell’s reducing power, and damages its 
macromolecules through oxidation. 
 We tested this hypothesis in vitro using pure lipoyl dehydrogenase by our ‘redox balance’ 
method. This quantifies the portion of electrons donated by the reductant (NADH) to chromate and to 
dioxygen). While only 24% of the electrons were consumed in 
reducing chromate, over 70% were used in ROS generation [8, 
9]. That chromate reduction by this enzyme involves extensive 
redox cycling is thus confirmed..  
4. In vivo effects of chromate reduction. Thus, certain 
bacterial enzymes can generate large amounts of ROS from 
chromate, producing little net conversion of Cr(VI) to CR(III).  
But does this in fact happen inside the cell? To test this we used 
the dye 2’, 7’-dihydrodichlorofluorescein (H2DCFDA), which is 
taken up by the cells and emits green fluorescence in the 
presence of ROS. The results (Fig. 2) [2] confirmed that cells 
experienced oxidative stress during chromate reduction. Further Figure 1. Growth inhibition and morphological 
changes (right images) generated by chromate.  
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indications of in vivo oxidative stress by chromate are: a) Cellular free thiols and glutathione levels 
decline; proteins involved in replenishing the thiol pools (CysN, CysK, sulfate adenylyl transferase) are 
upregulated, as is SodB that decomposes O.- [10-12]. b) Mutants strains missing the individual antioxidant 
defense genes, cysK, sodB, katE and yieF, showed greater sensitivity to chromate than the wild type. And 
c) the sfiA gene which is signature gene for the induction of the SOS response due to oxidative-stress is 
induced. Temporal analysis showed that the up-regulation of these proteins coincided with partial 
recovery of the cells from chromate stress (decreased H2DCFDA fluorescence; return to more normal cell 
morphology) [2].  
Oxidative stress is of course only a part of chromate stress. Cr(III), the desirable product of 
chromate reduction for bioremediation, is itself toxic [13]. However, from the perspective of using 
bacteria in remediating chromate, the difference between ROS and Cr(III) toxicity is critical. The former 
damages bacteria before they have had the chance to carry out the desired reaction; the latter does so 
after, and there may be a significant chance that a dead bacterium with Cr(III) complexed within it affords 
a means of immobilization. Thus, it would appear that 
minimizing chromate-mediated oxidative stress is critical for 
improving bacterial bioremediation capacity. 
5. Obligate two-electron reducers. How can oxidative 
stress engendered by chromate be minimized? Guidance on this 
came from studies in mammalian cells. They contain an enzyme, 
called DT diaphorase (NQO1), which is an obligatory two-
electron reducer of its substrates.  We hypothesized that if 
bacteria possessed a functional homologue of this enzyme then 
that enzyme could, as dimer, reduce chromate in one step. This would bypass Cr(V) generation, avoid 
redox cycling and generate Cr(III) with minimal ROS generation. Such a bacterial enzyme if made more 
active would outcompete the cellular one-electron chromate reducers and minimize chromate toxicity to 
the remediating bacteria. 
 Using a variety of approaches, we succeeded in purifying to homogeneity one such enzyme 
(ChrR) from P. putida [14]. Analyses showed that several bacteria possessed its sequence orthologues 
(~30%, amino acid identity), but no function assignment had been made to any of these proteins [15]. We 
have cloned the genes and extensively characterized two bacterial enzymes of this class, ChrR and YieF, 
as well as an unrelated enzyme (sequence-wise), NfsA, which has been extensively studied [16] but its 
capacity for obligatory two-electron reduction of chromate was not known prior to our work [9, 15]. Of 
these YieF was found to be the most tight obligatory two-electron chromate reducer with the widest 
substrate range, and was therefore chosen for further study. 
 That YieF reduces chromate without involving redox cycling was confirmed using multiple 
experimental approaches. The redox balance method showed that only 25% of the electrons donated by 
NADH were consumed in ROS generation, the rest being utilized in chromate reduction. Thus, the four-
electron reduced YieF dimer catalyzed a one-step three electron reduction of Cr(VI) to Cr(III), with the 
remaining electron simultaneously reacting with dioxygen to generate ROS, bypassing Cr(V) generation 
and redox cycling. That Cr(V) generation in fact did not occur was confirmed by rapid scan 
spectrophotometry that makes it possible to detect enzyme redox status at millisecond time scale. No 
flavin semiquinone enzyme form was detected, indicating absence of a one-electron transfer event [8]. 
Electron spin resonance measurements which permit direct detection of Cr(V) conducted with a related 
enzyme were consistent with these results [9]. Redox balance method indicates that YieF and its evolved 
enzymes reduce uranyl as well without redox cycling [17]. 
6. A strategy to mitigate chromate toxicity. Thus bacteria posses “safe” obligatory two electron 
reducers, and yet chromate generates oxidative stress (Section 4). Clearly the cellular one-electron 
reducers are more active than the safe enzymes. Would then overproduction in the cell of an enzyme of 
the safe type mitigate chromate toxicity? The answer is yes: when chromate reduction efficiency per unit 
growth between the wild type P. putida, a mutant missing ChrR, and a strain overproducing this protein 
Figure 2. Chromate engendered oxidative stress 
makes the dye fluoresce (right panel) 
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was tested, the mutant showed decreased, and the over-producer increased efficiency of chromate 
reduction per unit biomass [9]. 
 A strategy therefore presented itself for minimizing chromate toxicity to bacteria and improving 
their chromate remediation capability: Improve the kinetics of a safe enzyme for chromate reduction. 
We reasoned that a significantly active enzyme containing an appropriately high Kcat/Km would be able 
to sufficiently circumvent channeling of chromate in vivo into the unsafe pathways of one-electron 
reduction, thereby enabling bacteria to be more resilient in intracellular chromate reduction. This 
strategy is illustrated in Fig. 3. Indeed, this strategy should improve dissimilatory metal reduction as 
well, since these bacteria too are subject to oxidative stress by the mechanism described above. 
 Our studies with uranyl are less extensive so far. But all preliminary indications suggest a 
situation similar to Cr: aerobic reduction by cells; redox cycling by one-electron reducers; and “safe” 
reduction by obligatory two-electron reducers [17] (Salles and Matin, unpublished). 
7. Directed evolution of YieF. We thus conducted directed evolution of the YieF enzyme to 
improve its efficiency for chromate reduction followed by high throughput screening [17, 18]. Y6 
enzyme is the most effective isolated by this method with a 30-fold greater Vmax for chromate reduction 
than YieF as well as other improved characteristics (Table 1). Later studies showed that the evolved 
enzyme was markedly active also in uranyl reduction (Table 2). We have also used a colorimetric 
method for a direct high throughput screening of genes encoding improved uranyl reductase activity. 
Although several have been found, none so far encodes a protein more active in this respect than Y128 
and Y150 [18]. 
8. Rational 
approach to further YieF 
evolution. In collaboration 
with Dr. Yuval Nov (New 
York and Haifa 
Universities), we have also combined directed evolution approach with rational methods of enzyme 
improvement. Dr. Nov while at Stanford in Dr. Wein’s group [19] developed a system for optimizing 
protein activity under resource constraint, and devised a method to predict improved protein activity 
based on a limited number of protein variants. Applying his stochastic model relating the sequence and 
activity of a protein to the 16 mutants of the YieF enzyme involving mutations at 11 positions in the 
protein and Maximum Likelihood Analysis implemented through MATLAB's optimization toolbox, the 5 
two-point mutants with the highest predicted activity were 
identified and selected to be expressed and screened. All 5 
exhibited enhanced activity – on average, higher than the already 
high average activity of the 16 sequences in the initial data set (p < 
0.01). One of the five mutants, Y150, showed >830-fold 
improvement in activity over the wild type with respect to 
chromate reductase activity, making it the most active chromate 
reductase known (Tables 1 & 2; Barak, Y., Nov, Y., Matin, A. In 
preparation). This is the enzyme is the main focus of ongoing 
studies. 
  9. Evolved enzymes and cancer chemotherapy. Based on 
the general characteristics of YieF, Y6, and Y150, we tested the 
latter for prodrug reduction activity and found that they were 
highly effective in reducing disparate prodrugs, such as mitomycin C, 5-aziridinyl-2,4-dinitrobenzamide 
(CB 1954) and the drug 17-Allylamino-17-demethoxygeldanamycin (17-AAG) [18] (Barak, Y., Matin, A., 
unpublished). These prodrugs become activated upon reduction and are a highly promising approach to 
cancer chemotherapy, and thus a side-benefit of this research has been a potentially greatly improved 
prodrug therapy [18]. 
Table 1. Kinetics of Cr(VI) reduction of the wild type YieF and the evolved enzymes. 
Strain Vmax (nmol Cr(VI) mg protein -1 min -1) Km (µM) Kcat* (S-1) Kcat/Km 
YieF 295 ± 27 376 ± 14 30 ± 2 4.5x104 ± 3x103 
Y6 8,812 ± 611 41 ± 5 521 ± 18 1.3x107 ± 3x105 
Y150 258,333 ± 16,875 881 ± 353 57,445 ± 3,321 3x107 ± 1x106 
Figure 3. Strategy to minimize chromate 
toxicity to bacteria – circumventing chromate 
channeling to one-electron reducers. 
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 10. Amino acid changes underlying improved activity. Y6 exhibited four substitutions, however, 
reversion studies showed that only one change Tyr128 to Asn was responsible for its improved activity. 
Y150 has an additional 
substitution, Gly150 Ser.  
That relatively minor 
changes in the parent 
enzyme led to marked 
increases in activity for 
reducing disparate 
electrophiles suggests that the amino acid change(s) resulted in amplification of the original enzyme 
properties, including its broad substrate range, reinforcing the choice of YieF for these studies. They also 
provide the rationale for the hypothesis we would like to pursue that Y150 is likely to be more active also 
in reducing other radionuclides. Using the redox balance method and, in collaboration with the Francis 
group using XANES, we showed that the modification in the enzyme did not alter its characteristic for 
Cr(III) generation by a simultaneous four-electron chromate reduction [17, 18]. 
11. Envelope permeability-imposed limitation. We tested the efficacy of Y6 for chromate and 
uranyl reduction in P. putida. The broad host range vector pMMB67EH was used to introduce the YieF- 
or Y6- encoding genes (yieF and y6, respectively) into Pseudomonas (CRK4 strain). Bacteria over-
expressing YieF- or Y6 exhibited only marginally improved chromate 
reductase activity (Fig. 4A). However, cell extracts of the yieF-
transformed strain showed higher and those of y6-transformed strain 
even higher chromate reductase activity than the CRK4 extracts (Fig. 
4B). The results indicate that the E. coli genes yieF and its evolved 
versions were expressed in P. putida and suggest that the permeability 
barrier to chromate masked the enhanced cellular chromate reductase 
activity of the transformed strains. To further test the involvement of the 
transport barrier, the capacity of the transformed cells to reduce 
chromate was determined following their permeabilization by 
chloroform treatment. The recombinant strains expressing YieF and Y6 
now showed greater reductase activity than the non-transformed strain, 
with the Y6-expressing strain showing the highest activity (Fig 5).  
When the E. coli mutant NR698 which is impaired in outer 
membrane permeability [20] was transformed with these plasmids, the 
advantage of Y6 in whole cell reduction of chromate again became 
evident: the mutant expressing this enzyme reduced chromate at a faster 
rate than the wild type expressing the enzyme. Chloroform-treated 
MC4100 and NR698 (nonexpressing or overexpressing the cloned YieF 
or Y6) exhibited a greater reduction rate than untreated NR698 strain, 
but the difference was only 10-20%. Thus, while cytoplasmic membrane transport barrier also contributed 
to the masking of Y150 activity, the main barrier was the outer membrane impermeability.  
12. Uranyl reduction. Similar results were obtained with uranyl indicating the need to improve 
envelope permeability to take full advantage of the improved enzyme in enhancing bacterial capacity for 
uranyl reduction as well. Appropriate controls indicated that uranyl disappearance was not due to trivial 
reasons such as binding to medium constituents or to the cells [17]. Why was the reduced U not oxidized 
back to uranyl under the aerobic conditions used is not known. Whether sequestration of U(IV) within the 
cell and/or complexation with the medium are possibilities that are being investigated.. 
13. Physiological role of bacterial obligate two-electron reducing oxidoreductases. All of these 
enzymes also reduced quinones with high efficiency. Just as with chromate, many bacterial enzymes can 
vicariously reduce quinones by one electron reduction. This generates semiquinone which, like Cr(V), is 
subject to redox cycling, ROS and oxidative stress generation. Quinones are a constant potential threat to 
bacteria, being produced by cellular metabolism of aromatics and excreted by plants for defense against 
Table 2. Kinetics of U(VI) reduction of the wild type YieF and the evolved Y6 enzymes. 
Strai
n 
Vmax (nmol U(VI) mg protein -1 min -1) Km (µM) Kcat* (S-1) Kcat/Km 
YieF 213 ± 17 108 ± 49 29 ± 11 1.6x104 ± 1.7x103 
Y6 2,511 ± 421 779 ± 40 331 ± 39 5x105 ± 2x104 
Y150 4,814 ± 462 221 ± 54 333 ± 37 7x105 ± 7x104 
*Based on dimeric enzyme molecular mass of 50 kDa. 
Figure 4. A (upper panle). Cr(VI) 
conversion  by whole cells of P. putida, 
transformed with the empty plasmid, 
or plasmid containing the yieF or y6 
gene. ‘Control’ refers to chromate 
conversion in LB medium alone. B 
(lower panel). Chromate conversion by 
crude extracts of the above strains. 
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bacterial infections. All three obligate two-electron reducers we examined, YieF, ChrR, and NfsA, were 
able to outcompete one electron quinone reducers. Absence of ChrR and its overproduction made the cells 
less and more resistant, respectively, to H2O2 than the wild type. 
Fluorescent-activated cell sorting confirmed that the loss or 
overproduction of ChrR inside the cell correlates with intracellular 
levels of H2O2. Protein carbonylation, which reflects intracellular 
oxidative stress, corroborated these results. Thus, the obligate two-
electron bacterial oxidoreductases are designed to counter oxidative 
stress. Evidently, because of their broad substrate range, they can be 
recruited to minimize oxidative stress from compounds, such as 
chromate and quinones that have proclivity for one electron reduction 
[21]. 
 These findings reinforce two of the premises and objectives of 
this research, namely that strengthening the activity of these enzymes 
in the cells will make them more robust and efficient in stressful 
environments such as the DOE waste sites; and two, that they and 
their improved variants may be active in also reducing other metals 
and radionuclides to their stable reduced forms, since many of the 
latter also are likely to be subject to one-electron reduction. 
We have thus attained to a large degree the aim of the research 
namely evolving highly efficient enzymes that can enhance the capacity of bacteria for remediating 
multiple metal and radionuclide DOE contaminants while minimizing their toxicity to the bacteria. The 
stage is now set to explore the possibilities offered by these findings to extend the promise of Y150 type 
enzymes to: (a) encompass also reduction of additional DOE metals and radionuclides; (b) test the 
effectiveness of bacteria expressing Y150 to remediate metal and radionuclides in settings that resemble 
DOE site conditions; and (c) to determine their selective advantage and ecological impact in such settings. 
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